Chronic desipramine treatment selectively potentiates somatostatin-induced dopamine release in the nucleus accumbens

European Journal of Neuroscience

Volumn 14, Issue 4, 2001, Pages 763-767

  Pallis, Eleftherios ^a   Thermos, Kyriaki ^a   Spyraki, Christina ^a,b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Basal ganglia; Microdialysis; Neurotransmitter interactions

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DESIPRAMINE; DOPAMINE; HOMOVANILLIC ACID; SODIUM CHLORIDE; SOMATOSTATIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; ANIMAL; DEPRESSION; DRUG ADMINISTRATION; DRUG EFFECTS; DRUG INTERACTION; METABOLISM; MICRODIALYSIS; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SPRAGUE DAWLEY RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSION; DESIPRAMINE; DOPAMINE; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; HOMOVANILLIC ACID; MALE; MICRODIALYSIS; NEURONS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN;

EID: 0036283586     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0953-816X.2001.01698.x     Document Type: Article

References (26)

1. Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat
2. Effect of morphine applied by intrapallidal microdialysis on the release of dopamine in the nucleus accumbens
3. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
4. Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants
5. Somatostatin in the central nervous system: Physiological and pathological modifications
6. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients
7. Effects of acute and chronic desipramine treatment on somatostatin receptors in brain
8. Effect of antidepressant drugs on veratridine-evoked glutamate and aspartate release in rat prefrontal cortex
9. Phasic versus tonic DA release and the modulation of DA system responsitivity: A hypothesis for the etiology of schizophrenia
10. Somatostatin potently stimulates in vivo striatal dopamine and gamma-aminobutyric acid release by a glutamate-dependent action
11. Evidence that somatostatin sst2 receptors mediate striatal DA release
12. Striatal interneurons: Chemical, physiological and morphological characterization
13. Desmethylimipramine enhances the release of endogenous GABA and other neurotransmitter amino acids from the rat thalamus
14. CSF monoamine metabolites and somatostatin in Alzheimer's Disease and major depression
15. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens
16. Acute and chronic treatments with citalopram lower somatostatin levels in rat brain striatum through different mechanisms
17. Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats
18. Cerebrospinal fluid somatostatin and psychiatric illness
19. Biochemical and pharmacological characterization of somatostatin receptors in rat brain
20. Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rat
21. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine
22. The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from rat caudate nucleus
23. Dopamine-somatostatin interactions in the rat striatum: An in vivo microdialysis study
24. Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP) -like immunoreactivities and NADPH-diaphorase activity: A light and electron microscopic study
25. Dopaminergic mechanisms in depression and mania